Research Comparison
Dermorphin vs TB-500
A side-by-side research comparison of Dermorphin and TB-500 drawn from Cobalt Peptides' peptide database records.
Dermorphin
Dermorphin is a naturally derived heptapeptide originally isolated from the skin of South American tree frogs (Phyllomedusa species). It is a highly potent and selective μ-opioid receptor agonist, exhibiting significantly greater affinity and efficacy than endogenous opioid peptides such as endorphins. A unique structural feature of dermorphin is the presence of a D-alanine residue, which enhances receptor binding affinity and resistance to enzymatic degradation. In research settings, dermorphin is used to study opioid receptor signalling, pain modulation pathways, and peptide-receptor interactions.
TB-500
TB-500 is a synthetic 7-amino acid fragment (Ac-LKKTETQ) corresponding to the active actin-binding region (positions 17-23) of thymosin beta-4. Originally developed for veterinary use, this fragment retains tissue repair and anti-inflammatory properties while being more stable than the full peptide. TB-500 regulates actin dynamics, promotes cell migration, enhances angiogenesis, and reduces inflammation, contributing to accelerated tissue repair across multiple systems. Its systemic distribution enables whole-body regenerative support rather than localized effects alone.